Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
11
Number of overlapping holdings
45.8%
% of BBH's 26 holdings also in PBE
39.3%
% of PBE's 28 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 13.2% | 5.3% | 5.3% |
|
NATERA INC | 5.2% | 5.4% | 5.2% |
|
AMGEN INC | 16.4% | 5.0% | 5.0% |
|
REGENERON PHARMACEUTICALS | 5.2% | 4.4% | 4.4% |
|
BIOGEN IDEC INC | 3.3% | 4.7% | 3.3% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to PBE
|
VERTEX PHARMACEUTICALS INC | 12.6% |
|
AMGEN INC | 11.4% |
|
GILEAD SCIENCES INC | 7.9% |
 |
ARGENX SE ADR | 5.8% |
|
ALNYLAM PHARMACEUTICALS INC | 4.3% |
|
IQVIA HOLDINGS INC | 4.0% |
 |
ICON PLC | 3.2% |
 |
BIONTECH SE SPONSORED ADR | 2.8% |
|
INSMED INC | 2.7% |
|
MODERNA, INC. | 2.1% |
BBH Underweight Relative to PBE
|
UNITED THERAPEUTICS CORP | -4.5% |
|
PROTAGONIST THERAPEUTICS, INC. | -4.1% |
|
TG THERAPEUTICS INC | -4.0% |
|
CATALYST PHARMACEUTICAL PART | -3.3% |
|
HALOZYME THERAPEUTICS INC | -3.1% |
|
EXELIXIS INC | -3.0% |
|
ROYALTY PHARMA PLC CLASS A | -3.0% |
|
PTC THERAPEUTICS INC | -2.9% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -2.9% |
|
VERACYTE INC | -2.9% |